NCT05170464

Brief Summary

To determine the effects of moderate intensity exercise and caffeine on working memory in deprived caffeine consumers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Jan 2022

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 10, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 28, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

January 10, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

March 4, 2024

Status Verified

February 1, 2024

Enrollment Period

3 months

First QC Date

December 10, 2021

Last Update Submit

February 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Working Memory as assessed by N-back task

    Participants will complete three n-back assessments, one baseline, one after 24 hours of caffeine deprivation, and one after treatment (either caffeine ingestion or acute exercise). Percent error rates will be compared.

    Baseline and 24 hours later (deprived and post-treatment).

Study Arms (2)

Acute Exercise

EXPERIMENTAL

20 minutes of moderate intensity acute exercise (treadmill speed to achieve ⅔ of maximum heart rate).

Behavioral: Acute Exercise

Caffeine Ingestion

ACTIVE COMPARATOR

1.2mg/kg of powdered caffeine (Caffeine powder, ReagentPlus® from Sigma-Aldrich) dissolved in 1 cup of water then sitting for 20 minutes.

Drug: Caffeine Powder

Interventions

Acute ExerciseBEHAVIORAL

Brisk walking on a treadmill at ⅔ maximum heart rate as defined by 220-age (in years).

Also known as: Aerobic Exercise
Acute Exercise

Participants will receive powdered caffeine dissolved in one cup of water (1.2mg/kg)

Also known as: Caffeine Ingestion
Caffeine Ingestion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Are over the age of 18 years
  • Consume at least 150 mg of caffeine a day
  • Do not have any cognitive problems
  • Are not pregnant
  • Do not have a medical condition that prevents you to exercise
  • Do not have an orthopaedic limitation
  • Have access to a telephone or an email account for communication
  • Can read and write in English

You may not qualify if:

  • Participants taking prescription medication for depression or anxiety
  • Participants that cannot give informed consent will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Western Ontario

London, Ontario, Canada

Location

Related Publications (1)

  • Morava A, Fagan MJ, Prapavessis H. Effects of Caffeine and Acute Aerobic Exercise on Working Memory and Caffeine Withdrawal. Sci Rep. 2019 Dec 23;9(1):19644. doi: 10.1038/s41598-019-56251-y.

    PMID: 31873185BACKGROUND

MeSH Terms

Conditions

Memory Disorders

Interventions

Exercise

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Harry Prapavessis, PhD

    Western University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, School of Kinesiology

Study Record Dates

First Submitted

December 10, 2021

First Posted

December 28, 2021

Study Start

January 10, 2022

Primary Completion

March 31, 2022

Study Completion

April 1, 2022

Last Updated

March 4, 2024

Record last verified: 2024-02

Locations